These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 6375217)

  • 1. [Capsule formation and virulence in staphylococci].
    Oleĭnik II; Pokrovskiĭ VN; Zhukovitskiĭ VG
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Mar; (3):19-25. PubMed ID: 6375217
    [No Abstract]   [Full Text] [Related]  

  • 2. The relationship of capsular-type of Staphylococcus epidermidis to virulence and induction of resistance in the mouse.
    Ichiman Y; Yoshida K
    J Appl Bacteriol; 1981 Oct; 51(2):229-41. PubMed ID: 7298531
    [No Abstract]   [Full Text] [Related]  

  • 3. Cross protection between an encapsulated strain of Staphylococcus hyicus and encapsulated strains of Staphylococcus aureus.
    Yoshida K; Ichiman Y; Umeda A
    J Appl Bacteriol; 1988 Dec; 65(6):491-9. PubMed ID: 3243729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Capsule production and virulence among strains of Staphylococcus aureus.
    Wiley BB; Maverakis NH
    Ann N Y Acad Sci; 1974 Jul; 236(0):221-32. PubMed ID: 4138896
    [No Abstract]   [Full Text] [Related]  

  • 5. Virulence studies, in mice, of transposon-induced mutants of Staphylococcus aureus differing in capsule size.
    Lee JC; Betley MJ; Hopkins CA; Perez NE; Pier GB
    J Infect Dis; 1987 Nov; 156(5):741-50. PubMed ID: 2821124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of anticapsular antibodies on neutrophil phagocytosis of Staphylococcus aureus.
    Guidry AJ; Oliver SP; Squiggins KE; Erbe EF; Dowlen HH; Hambleton CN; Berning LM
    J Dairy Sci; 1991 Oct; 74(10):3360-9. PubMed ID: 1744265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective opsonic activity of antibodies against fibronectin-binding proteins (FnBPs) of Staphylococcus aureus.
    Rozalska B; Wadström T
    Scand J Immunol; 1993 May; 37(5):575-80. PubMed ID: 8484103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Staphylococcal heat-stable opsonins.
    Humphreys DW; Wheat LJ; White A
    J Lab Clin Med; 1974 Jul; 84(1):122-8. PubMed ID: 4134581
    [No Abstract]   [Full Text] [Related]  

  • 9. Protection against Staphylococcus aureus by antibody to the polyglycerolphosphate backbone of heterologous lipoteichoic acid.
    Theilacker C; Kropec A; Hammer F; Sava I; Wobser D; Sakinc T; Codée JD; Hogendorf WF; van der Marel GA; Huebner J
    J Infect Dis; 2012 Apr; 205(7):1076-85. PubMed ID: 22362863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Milk complement and the opsonophagocytosis and killing of Staphylococcus aureus mastitis isolates by bovine neutrophils.
    Barrio MB; Rainard P; Poutrel B
    Microb Pathog; 2003 Jan; 34(1):1-9. PubMed ID: 12620379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Animal and human antibodies to distinct Staphylococcus aureus antigens mutually neutralize opsonic killing and protection in mice.
    Skurnik D; Merighi M; Grout M; Gadjeva M; Maira-Litran T; Ericsson M; Goldmann DA; Huang SS; Datta R; Lee JC; Pier GB
    J Clin Invest; 2010 Sep; 120(9):3220-33. PubMed ID: 20739753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New aspects of staphylococcal infections: emergence of coagulase-negative staphylococci as pathogens.
    Fleer A; Verhoef J
    Antonie Van Leeuwenhoek; 1984; 50(5-6):729-44. PubMed ID: 6397138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Staphylococcal opsonization and anti-Staphylococcus aureus IgG subclass antibodies in patients with severe or recurrent S. aureus infections.
    Monteil MA; Kaniuk AS; Hobbs JR
    FEMS Microbiol Immunol; 1990 Dec; 2(5-6):259-62. PubMed ID: 2073408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Staphylococci in the induction of delayed and immediate hypersensitivity].
    Sukhodoeva GS
    Zh Mikrobiol Epidemiol Immunobiol; 1982 Mar; (3):5-11. PubMed ID: 6177129
    [No Abstract]   [Full Text] [Related]  

  • 15. Virulence of Staphylococcus aureus mutants altered in type 5 capsule production.
    Albus A; Arbeit RD; Lee JC
    Infect Immun; 1991 Mar; 59(3):1008-14. PubMed ID: 1847696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological properties of the encapsulated Staphylococcus aureus M.
    Melly MA; Duke LJ; Liau DF; Hash JH
    Infect Immun; 1974 Aug; 10(2):389-97. PubMed ID: 4604161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Humoral immune response to staphylococcal antigens in the clinic and in an experiment].
    Liashchenko KP; Bobrovnik SA
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Apr; (4):104-10. PubMed ID: 3300107
    [No Abstract]   [Full Text] [Related]  

  • 18. The staphylococcal surface-glycopolymer wall teichoic acid (WTA) is crucial for complement activation and immunological defense against Staphylococcus aureus infection.
    Kurokawa K; Takahashi K; Lee BL
    Immunobiology; 2016 Oct; 221(10):1091-101. PubMed ID: 27424796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative immunochemical characteristics of extracellular polysaccharide-containing preparations and teichoic acids of Staphylococcus aureus].
    Iastrebova NE; Vaneeva NP; Mezhevitinov VB; Stepanova OV
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Aug; (8):14-8. PubMed ID: 3765969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Erythrocyte reagents for detecting antibodies to species-specific staphylococcal antigens].
    Deriabin PN; Karal'nik BV
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Jun; (6):87-90. PubMed ID: 4036419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.